The global urology surgical instruments market size is expected to reach USD 20.36 billion by 2030, registering a CAGR of 8.1%, according to a new report by Grand View Research, Inc. Growing geriatric population, increasing prevalence of urinary disorders, rising preference for minimally invasive surgeries, surging R&D investments, and ongoing product launches by manufacturers are some of the key factors driving this market.
According to the National Association for Continence, one in five individuals over the age of 40 suffers from urine urgency, overactive bladder, or leakage of urine. Urinary incontinence is highly prevalent among geriatric population and often results in poor quality of life, high costs, and morbidity. As per the American Society of Nephrology, urologic issues are the third most common complaint among people 65 years and above and they account for approximately 47.0% of visits to the physician. Thus, rising geriatric population could lead to increase in prevalence of urinary problems, thereby boosting demand for urology surgical instruments in the coming years.
There has been growing preference for minimally invasive surgeries (MIS) in gynecology and urology in recent years. Many manufacturers are focusing on development of products to be used for such procedures. For instance, in FY 2017, the research and development expenses of Olympus Corporation were pegged at USD 355.21 million. Similarly, the R&D costs of Coloplast in 2016/17 were nearly USD 94.08 million (DKK 574 million). This has increased from USD 83.43 million (DKK 509 million) in 2015/16. These R&D investments aid in development and launch of new products in the market.
Request a free sample copy or view report summary: Urology Surgical Instruments Market Report
By product, the consumables and accessories segment held majority of the market in 2022 due to repeated usage of these products and their disposable nature
On the basis of application, chronic kidney diseases (CKD) held the dominant share in 2022 owing to rise in cases of CKD, increasing number of clinical trials for new non-invasive procedures to treat these conditions, and initiatives by governments across the globe
North America dominated the global market owing to an increase in demand for minimally invasive urology surgeries, positive reimbursement scenario, and high adoption of advanced technologies
Asia Pacific is anticipated to witness the fastest growth owing to improving healthcare infrastructure, rising prevalence of urology disorders, and growing popularity of this region as a destination for medical tourism
Grand View Research has segmented the global urology surgical instruments market report based on the product, application, and region:
Urology Surgical Instruments Product Outlook (Revenue, USD Million, 2018 - 2030)
Endoscopes
Laparoscopes
Ureteroscopes
Nephroscopes
Resectoscopes
Cystoscopes
Endovision Systems
Light Sources
Cameras
Camera Heads
Monitors & Displays
Peripheral Systems
Insufflators
Endoscopy Fluid Flushing Devices
Consumables & Accessories
Guidewires
Stone Baskets/Retrieval Devices and Extractors
Catheters
Stents
Biopsy Devices
Fluid Flushing Devices, Connecting Tubes, Clamps, Overtubes, and Distal Attachments
Dilator Sets and Ureteral Access Sheaths
Drainage Bags
Surgical Dissectors
Needle Forceps and Needle Holders
Others
Urology Surgical Instruments Application Outlook (Revenue, USD Million, 2018 - 2030)
Chronic Kidney Diseases (CKD)
Benign Prostatic Hyperplasia (BPH)
Urinary Stones
Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)
Oncology
Other Applications
Urology Surgical Instruments Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
UAE
Kuwait
Saudi Arabia
List of Key Players in the Urology Surgical Instruments Market
Medtronic
Boston Scientific Corporation
Olympus Corporation
Karl Storz GmbH & Co. KG
Cook Medical LLC
Richard Wolf GmbH
Stryker
Teleflex Incorporated
Coloplast Group
"The quality of research they have done for us has been excellent..."